Cargando…
Diversity and Recognition Efficiency of T Cell Responses to Cancer
BACKGROUND: Melanoma patients vaccinated with tumor-associated antigens frequently develop measurable peptide-specific CD8+ T cell responses; however, such responses often do not confer clinical benefit. Understanding why vaccine-elicited responses are beneficial in some patients but not in others w...
Autores principales: | Stuge, Tor B, Holmes, Susan P, Saharan, Sahdev, Tuettenberg, Andrea, Roederer, Mario, Weber, Jeffrey S, Lee, Peter P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC529423/ https://www.ncbi.nlm.nih.gov/pubmed/15578105 http://dx.doi.org/10.1371/journal.pmed.0010028 |
Ejemplares similares
-
Cytotoxic T lymphocyte responses against melanocytes and melanoma
por: Chang, Gwendolen Y, et al.
Publicado: (2011) -
Authors' Reply
por: Stuge, Tor B, et al.
Publicado: (2005) -
Marked Differences in Human Melanoma Antigen-Specific T Cell Responsiveness after Vaccination Using a Functional Microarray
por: Chen, Daniel S, et al.
Publicado: (2005) -
Multifunctional analysis of antigen-specific T cells: correlates of vaccine efficiency
por: Roederer, Mario
Publicado: (2010) -
Current perspectives on fetal and neonatal alloimmune thrombocytopenia – increasing clinical concerns and new treatment opportunities
por: Tiller, Heidi, et al.
Publicado: (2017)